Print

Acambis (ACAM) Says Japanese Encephalitis Trial Positive  
10/30/2006 3:17:35 PM

LONDON, Oct 30 (Reuters) - UK vaccine maker Acambis said on Monday it had received positive results from a final Phase III safety trial of its experimental vaccine for Japanese encephalitis, and encouraging preliminary efficacy data.
//-->